Showing 1 – 20 of 1469
Relevance | Newest | Oldest |
  • JAMA October 11, 2017

    Figure: Opioid Use and Overdose and Fentanyl Drug Reports, 1999-2015

    aSource: National Center for Health Statistics at the US Centers for Disease Control and Prevention. WONDER online database: prescription opioid overdose deaths include fatal overdoses related to natural and semisynthetic opioids or methadone. Illicit opioid-related overdose deaths are related to heroin or synthetic nonmethadone opioids, and some overdose deaths are related to prescribed fentanyl or other prescribed synthetic opioids.bSource: Substance Abuse and Mental Health Services Administration. National Survey on Drug Use and Health. Dashed line from 1999 to 2005 (Drug Enforcement Administration. Automation of Reports and Consolidated Orders System: sales to pharmacies, hospitals, and practitioners for codeine, fentanyl, hydrocodone, hydromorphone, meperidine, methadone, morphine, and oxycodone. Paulozzi LJ, et al. MMWR Morb Mortal Wkly Rep. 2011;60:1487-1492). Solid line from 2006 to 2015 (QuintilesIMS estimates of opioid prescriptions dispensed in the United States to 59 000 pharmacies, representing 88% of US prescriptions. Guy GP Jr, et al. MMWR Morb Mortal Wkly Rep. 2017;66:697-704).dSource: Drug Enforcement Administration. Fentanyl, 2001-2015. The number of fentanyl drug reports reflects the number of encounters by law enforcement that tested positive for fentanyl. Therefore, fentanyl drug reports provide an indication of the available supply of illicitly manufactured fentanyl.
  • Suppression of Substance Abuse Claims in Medicaid Data and Rates of Diagnoses for Non–Substance Abuse Conditions

    Abstract Full Text
    free access
    JAMA. 2016; 315(11):1164-1166. doi: 10.1001/jama.2015.18417

    This study examines the association between implementation of a Centers for Medicare & Medicaid Services policy mandating suppression of substance abuse–related claims in Medicare and Medicaid Research Identifiable Files and rates of diagnoses for non–substance abuse conditions in those data.

  • Brief Intervention for Problem Drug Use in Safety-Net Primary Care Settings: A Randomized Clinical Trial

    Abstract Full Text
    free access
    JAMA. 2014; 312(5):492-501. doi: 10.1001/jama.2014.7860
  • JAMA August 6, 2014

    Figure 1: Participant Flow in the Trial of a Brief Intervention for Problem Drug Use

    aInclusion criteria were age 18 years or older; self-reported use of an illegal drug or nonprescribed medication (ie, problem drug use) at least once in the 90 days before screening; English-speaking and able to read and understand screening and consent forms (sixth-grade literacy); currently receiving and planning to continue care in the clinic; and having telephone or e-mail access to facilitate scheduling follow-up assessments. Exclusion criteria were attendance in formal substance abuse treatment in the past month (excluding self-help groups such as Narcotics Anonymous); high risk of imminent suicide; life-threatening medical illness; severe cognitive impairment; or active psychosis. Data for reasons of exclusion are not available.
  • Healthy People 2020: A Report Card on the Health of the Nation

    Abstract Full Text
    free access
    JAMA. 2014; 311(24):2475-2476. doi: 10.1001/jama.2014.6446
  • JAMA November 13, 2013

    Figure 6: Percent Distribution of National Health Expenditures by Source of Funds, 1980-2011

    The percent distribution of national health expenditures by source of funds was calculated based on data obtained from the Centers for Medicare & Medicaid Services.aOther third-party payers and programs include work-site health care, school health, other private revenues, Indian Health Services, workers’ compensation, general assistance, maternal/child health, vocational rehabilitation, and Substance Abuse and Mental Health Services Administration.bOther government health insurance programs include Child Health Insurance Program, Department of Defense, and Department of Veterans Affairs.cOut-of-pocket spending for health care consists of direct spending by consumers for health care goods and services. Included in this estimate is the amount paid out of pocket for services not covered by insurance and the amount of coinsurance or deductibles required by private health insurance and public programs such as Medicare and Medicaid (not paid by some other third party), as well as payments covered by health savings accounts.
  • Preventing Suicide’s Ripple Effects Takes Coordinated Effort

    Abstract Full Text
    JAMA. 2013; 310(6):570-571. doi: 10.1001/jama.2013.117024
  • Treatment of Comorbid Substance Dependence and Posttraumatic Stress Disorder

    Abstract Full Text
    JAMA. 2013; 310(5):482-483. doi: 10.1001/jama.2013.8269
  • Addiction: White House Seeks “Third Way”: Policy Emphasizes Prevention, Treatment, Recovery

    Abstract Full Text
    JAMA. 2013; 309(21):2201-2202. doi: 10.1001/jama.2013.6001
  • Treatment of Substance Abuse in Military Hampered by “Old-fashioned” Approach

    Abstract Full Text
    JAMA. 2012; 308(18):1845-1846. doi: 10.1001/jama.2012.13704
  • JAMA August 1, 2012

    Figure: WHO Documents Worldwide Need for Better Drug Abuse Treatment—and Access to It

    Substance abuse remains prevalent around the globe, but treatment access lags, according to a new database set up by the World Health Organization to track the availability of services to prevent and treat substance use disorders.
  • US Medical Students’ Health Insurance Coverage for Mental Health and Substance Abuse Treatment

    Abstract Full Text
    free access
    JAMA. 2011; 306(9):931-933. doi: 10.1001/jama.2011.1262
  • Substance Abuse Service

    Abstract Full Text
    JAMA. 2011; 305(20):2056-2056. doi: 10.1001/jama.2011.680
  • Treatment Is Lacking for Many US Adults With Mental Illness or Substance Abuse

    Abstract Full Text
    JAMA. 2011; 305(1):27-27. doi: 10.1001/jama.2010.1898
  • Violent Behavior in Mental Illness: The Role of Substance Abuse

    Abstract Full Text
    JAMA. 2010; 304(5):563-564. doi: 10.1001/jama.2010.1097
  • Integrated Care Key for Patients With Both Addiction and Mental Illness

    Abstract Full Text
    JAMA. 2010; 303(19):1905-1907. doi: 10.1001/jama.2010.597
  • Applying Health Care Reform Principles to Mental Health and Substance Abuse Services

    Abstract Full Text
    JAMA. 2009; 302(13):1463-1464. doi: 10.1001/jama.2009.1446
  • Schizophrenia, Substance Abuse, and Violent Crime

    Abstract Full Text
    free access
    JAMA. 2009; 301(19):2016-2023. doi: 10.1001/jama.2009.675
  • JAMA October 1, 2008

    Figure 1: Participant Flow for the Centers for Disease Control and Prevention Anthrax Vaccine Research Program Human Clinical Trial

    “Terminated injections” means that no more injections will be received by that participant. “Suspended injections” means that the participant is anticipated, or has agreed, to resume injections later in the study. A participant listed as “unable to contact” in the suspended group may be expected to resume injections. IM indicates intramuscular; SQ, subcutaneously.a Indicates that reasons for exclusion included abnormal electrocardiogram results, allergy to aluminum, autoimmune disorder, chronic condition or disease, compromised injection site, current or planned pregnancy, genetic disorder, history of anthrax vaccine adsorbed injections, history of or current cancer, mental illness, military commitment, neurologic condition, ongoing immune suppression therapy, planned surgery, poor venous access, security risk, and substance abuse.
  • JAMA August 6, 2008

    Figure: Integrated Care Needed for Patients With HIV, Drug Abuse, and Mental Illness

    Treating substance abuse has a collateral benefit of reducing HIV transmission. Researchers have found that opioid users who receive methadone treatment for their addiction are substantially less likely to become infected with HIV than are opioid users who are not in treatment.